Use the collections feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
REVIEW
Valerio Nobili, Anna Alisi, Giovanni Musso, Eleonora Scorletti, Philip C Calder, Christopher D Byrne
Non-alcoholic fatty liver disease (NAFLD) is currently considered the most common liver disease in industrialized countries, and it is estimated that it will become the most frequent indication for liver transplantation in the next decade. NAFLD may be associated with moderate (i.e. steatosis) to severe (i.e. steatohepatitis and fibrosis) liver damage and affects all age groups. Furthermore, subjects with NAFLD may be at a greater risk of other obesity-related complications later in life, and people with obesity and obesity-related complications (e...
2016: Critical Reviews in Clinical Laboratory Sciences
#2
REVIEW
Vikas Gupta, Xian-Jun Mah, Maria Carmela Garcia, Christina Antonypillai, David van der Poorten
Rates of non-alcoholic fatty liver disease (NAFLD) are increasing worldwide in tandem with the metabolic syndrome, with the progressive form of disease, non-alcoholic steatohepatitis (NASH) likely to become the most common cause of end stage liver disease in the not too distant future. Lifestyle modification and weight loss remain the main focus of management in NAFLD and NASH, however, there has been growing interest in the benefit of specific foods and dietary components on disease progression, with some foods showing protective properties...
October 7, 2015: World Journal of Gastroenterology: WJG
#3
LETTER
Raquel S Torrinhas, Dan L Waitzberg
No abstract text is available yet for this article.
February 2016: Journal of Clinical Gastroenterology
1
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
